| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |